Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05785208 |
| Title | Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status. (TEMPLE-2) |
| Acronym | TEMPLE-2 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |